These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19539054)

  • 61. Clostridium difficile: improving the prevention paradigm in healthcare settings.
    Vassallo A; Tran MC; Goldstein EJ
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1087-102. PubMed ID: 25109301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibiotics and Clostridium difficile.
    Freeman J; Wilcox MH
    Microbes Infect; 1999 Apr; 1(5):377-84. PubMed ID: 10602670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencing.
    Jia H; Du P; Yang H; Zhang Y; Wang J; Zhang W; Han G; Han N; Yao Z; Wang H; Zhang J; Wang Z; Ding Q; Qiang Y; Barbut F; Gao GF; Cao Y; Cheng Y; Chen C
    BMC Genomics; 2016 May; 17():405. PubMed ID: 27411304
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
    Durham DP; Olsen MA; Dubberke ER; Galvani AP; Townsend JP
    Emerg Infect Dis; 2016 Apr; 22(4):608-16. PubMed ID: 26982504
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic markers for Clostridium difficile lineages linked to hypervirulence.
    Knetsch CW; Hensgens MPM; Harmanus C; van der Bijl MW; Savelkoul PHM; Kuijper EJ; Corver J; van Leeuwen HC
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3113-3123. PubMed ID: 21873406
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Control of Clostridium difficile infection in the hospital setting.
    Wiuff C; Murdoch H; Coia JE
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):457-69. PubMed ID: 24579852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Infectious diseases. DNA sleuths track C. difficile infection routes.
    Sinha G
    Science; 2013 Sep; 341(6153):1440. PubMed ID: 24072898
    [No Abstract]   [Full Text] [Related]  

  • 68. Possible Interplay Between Hospital and Community Transmission of a Novel Clostridium Difficile Sequence Type 295 Recognized by Next-Generation Sequencing.
    Moloney G; Mac Aogáin M; Kelleghan M; O'Connell B; Hurley C; Montague E; Conlon M; Murray H; Rogers TR
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):680-4. PubMed ID: 27074865
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biology of Clostridium difficile: implications for epidemiology and diagnosis.
    Carroll KC; Bartlett JG
    Annu Rev Microbiol; 2011; 65():501-21. PubMed ID: 21682645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization.
    Spigaglia P; Barketi-Klai A; Collignon A; Mastrantonio P; Barbanti F; Rupnik M; Janezic S; Kansau I
    J Med Microbiol; 2013 Sep; 62(Pt 9):1386-1393. PubMed ID: 23518658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Policy development for Clostridium difficile.
    Wilcox MH
    J Antimicrob Chemother; 2012 Jul; 67 Suppl 1():i19-22. PubMed ID: 22855874
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clostridium difficile.
    Stoddart B; Wilcox MH
    Curr Opin Infect Dis; 2002 Oct; 15(5):513-8. PubMed ID: 12686885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diversity and Evolution in the Genome of Clostridium difficile.
    Knight DR; Elliott B; Chang BJ; Perkins TT; Riley TV
    Clin Microbiol Rev; 2015 Jul; 28(3):721-41. PubMed ID: 26085550
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clostridium difficile: no longer an enigmatic pathogen?
    Roberts AP; Mullany P
    Methods Mol Biol; 2010; 646():3-7. PubMed ID: 20596999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis.
    Kansau I; Barketi-Klai A; Monot M; Hoys S; Dupuy B; Janoir C; Collignon A
    PLoS One; 2016; 11(6):e0158204. PubMed ID: 27351947
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phenotypic characterisation of Clostridium difficile reveals lack of extracellular virulence factor production and significant differences in antibiogram profiles.
    Green LM; Worthington T; Hilton AC; Lambert PA
    Int J Antimicrob Agents; 2010 Mar; 35(3):305-6. PubMed ID: 20031376
    [No Abstract]   [Full Text] [Related]  

  • 77. 12th C. L. Oakley lecture. Pathogenesis of Clostridium difficile infection of the gut.
    Borriello SP
    J Med Microbiol; 1990 Dec; 33(4):207-15. PubMed ID: 2258909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dissemination of Clostridium difficile in food and the environment: Significant sources of C. difficile community-acquired infection?
    Warriner K; Xu C; Habash M; Sultan S; Weese SJ
    J Appl Microbiol; 2017 Mar; 122(3):542-553. PubMed ID: 27813268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis.
    Wilcox MH
    Best Pract Res Clin Gastroenterol; 2003 Jun; 17(3):475-93. PubMed ID: 12763508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clostridium difficile is emerging in Romania: a story of 027 ribotype and excessive antibiotic consumption.
    Popescu GA; Florea D; Rafila A
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):342-3. PubMed ID: 25267968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.